Which innovative supply chain strategy was NOT widely adopted by the pharmaceutical industry during the COVID-19 pandemic to improve resilience?

During the COVID-19 pandemic, medical supply chains were tested like never before. Hospitals, pharmacies, and healthcare systems faced unprecedented challenges in sourcing critical supplies from PPE to medications. This crisis prompted significant innovation and transformation in how the healthcare industry approaches supply chain management, with many lessons learned that continue to reshape medical logistics today.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Nearshoring of API (Active Pharmaceutical Ingredient) production
Implementation of blockchain technology for end-to-end supply chain visibility
Adoption of AI-powered predictive analytics for demand forecasting
Complete nationalization of pharmaceutical manufacturing in major markets